Table 1.
Characteristics of participants.
| Patient experts (N = 7) | Other experts (N = 16) | |
|---|---|---|
| Country | ||
| European Union | – | 3 |
| Canada | – | 3 |
| United Kingdom | 7 | 4 |
| United States | – | 6 |
| Role | ||
| Regulator | – | 5 |
| Academic researcher | – | 7 |
| Payer | – | 1 |
| Industry expert | – | 3 |
| Patient | 5 | – |
| Patient advocate | 2 | – |
| Gender | ||
| Male | 5 | 6 |
| Female | 2 | 10 |